Gökben Baskaynak

Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588

Philipp le Coutre, Karl‐Anton Kreuzer, Stefan Pursche et al. · Cancer Chemotherapy and Pharmacology · 2003 · 158 citations

Physiologically-based Pharmacokinetic Modeling, Medicine, Cellular Uptake +6

Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR

Joachim Lupberger, Karl‐Anton Kreuzer, Gökben Baskaynak et al. · Molecular and Cellular Probes · 2002 · 121 citations

Porphobilinogen Deaminase Mrna, Systems Biology, Protein Expression +7

Imatinib‐induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia

Michaela Schwarz, Karl‐Anton Kreuzer, Gökben Baskaynak et al. · European Journal Of Haematology · 2002 · 60 citations · Full text

Immunology, Pathology, Exanthematous Pustulosis +16

Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia

Urban Novak, Tobias Grob, Gökben Baskaynak et al. · Annals of Oncology · 2001 · 47 citations · Full text

Hematological Malignancy, Novel Finding, P73 Gene +10

Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis.

U Peters, Mario P. Tschan, Karl‐Anton Kreuzer et al. · PubMed · 1999 · 43 citations

Mixed-phenotype Acute Leukemia, Pathology, Cancer Biology +20